HOME >> BIOLOGY >> NEWS
UAlbany CNSE enters NanoBio alliance with Albert Einstein College of Medicine

lege is participating as a partner in the CNSE Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2), which was recently designated by NYSTAR. Joint research thrusts focus on investigating and optimizing the interface between the world of biology and the world of nanofabrication to develop "bio-systems on a chip" (B-SOCs) for medical and biomedical applications.

About the Albert Einstein College of Medicine

Albert Einstein College of Medicine of Yeshiva University, now celebrating its 50th anniversary, is one of the nation's premier institutions for medical education, basic research and clinical investigation. A full-time faculty of more than 2,000 teaches, delivers health care and conducts research in every major biomedical specialty. Particular areas of research strength for which Einstein is widely renowned include: cancer, diabetes, heart disease, molecular genetics, immunology, liver diseases, Alzheimer's disease and neuroscience. Located in the Bronx, N.Y., Einstein is also recognized as a leader in the development of a socially conscious approach to medicine.

About CNSE

The College of Nanoscale Science and Engineering at the University at Albany SUNY is the first college in the world devoted exclusively to the development and deployment of innovative nanoscience concepts. Located within the Albany NanoTech complex, a $1 billion center for public/private nanotechnology research and development, CNSE's facilities are unparalleled in the academic word. With over 100 industrial partners on site, including IBM, Infineon, AMD, GE and Tokyo Electron, students and faculty work alongside scientists from industry on fundamental cutting-edge research underlying the real-world problems that most concern industry.


'"/>

Contact: Shonna Keogan
skeogan@uamail.albany.edu
917-660-7462
Albany NanoTech College of Nanoscale Science and Engineering
21-Feb-2005


Page: 1 2 3

Related biology news :

1. AEA, UAlbany College of Nanoscale Science and Engineering to partner on CIRCA 07
2. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
3. Researchers develop marker that identifies energy-producing centers in nerve cells
4. NHGRI funds large-scale sequencing centers
5. Worcester Polytechnic Institute receives $2 million in federal funds for biomedical research centers
6. Nanoparticle assembly enters the fast lane
7. Burnham awarded $12.7 million from NIH to create one of nations top neuroscience research centers
8. Food or its expectation sparks brains hunger centers
9. Burroughs Wellcome Fund to support Project Suc-SEED at CIIT Centers for Health Research
10. Wounds may one day heal better, faster, due to new NIH-funded wound healing centers
11. NHGRI awards $54 million to three Centers of Excellence in Genomic Science

Post Your Comments:
(Date:11/21/2014)... , Nov. 20, 2014 Strict laws ... efficiency are piloting the North American and European automotive ... accidents growing, gesture recognition systems that are intuitive and ... mark in the industry. New analysis ... Gesture Recognition Market in Europe ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
(Date:12/15/2014)...  Ascendis Pharma A/S, a biotechnology company that ... unmet medical needs, today announced positive six-month interim ... to evaluate once-weekly TransCon Growth Hormone in children ... analysis consists of 25 patients, representing approximately 50% ... completing all six months of treatment. ...
(Date:12/13/2014)... The DNA Microarray market market was ... expected to grow at a CAGR of 15.2% ... TOC of the DNA Microarray for an in-depth ... help of various tables and figures. , ... consists of instrument, consumables, and services, where the ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4
Cached News: